VALYSTR · Stock research
Listed on NasdaqGM. What the market is pricing into Entrada Therapeutics, Inc. (TRDA) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $184M · revenue $4.7M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows